María L. García - Concepedia

Author

María L. García

Universitat de Barcelona ORCID

Also Known As

Budi Sasongko, M Cubells, M Garca, M Garcia, M L Garcia, M L García, M. Garcia, M. García, M. L. GARCIA, M. L. Garcia

484

Publications

27.3K

Citations

H-Index

218

Concepts

All Affiliations

Universitat de Barcelona Merck & Co., Inc., Rahway, NJ, USA (United States)Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona University of Trás-os-Montes and Alto Douro University of Coimbra

About

María L. García is an author at Universitat de Barcelona specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	129	8.2K
2	Engineering	36	60	4.1K
3	Natural Sciences	27	40	2.7K
4	Health Sciences	18	19	1.4K
5	Social Sciences	9	9	844

María L. García

264

Publications

18.6K

Citations

H-Index

Page 1

	Year	Citations
Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. Antonio Gálvez, Guillermo Giménez‐Gallego, J. P. Reuben, Journal of Biological Chemistry	1990	700
Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release Richard Robitaille, María L. García, Gregory J. Kaczorowski, Neuron Hyperpolarization (Biology)NeurophysiologySynaptic TransmissionPhysiologyIon Channels	1993	444
A unified nomenclature for short-chain peptides isolated from scorpion venoms: α-KTx molecular subfamilies Jan Tytgat, K. George Chandy, María L. García, Trends in Pharmacological Sciences BiochemistryNatural SciencesPeptide LibraryVenomicsMolecular Biology	1999	382
Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. Margarita García‐Calvo, Reid J. Leonard, J. Novick, Journal of Biological Chemistry ToxinologyMolecular PhysiologySignal TransductionBiochemistryVoltage-dependent Potassium Channels	1993	345
Primary sequence and immunological characterization of beta-subunit of high conductance Ca(2+)-activated K+ channel from smooth muscle. H G Knaus, Kimberly Folander, M. Garcia-Calvo, Journal of Biological Chemistry Proteinlipid InteractionMuscle FunctionCharybdotoxin ReceptorCytoskeletonBiomedical Engineering	1994	322
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model Amanda Cano, Miren Ettcheto, Jui-Hsien Chang, Journal of Controlled Release	2019	315
ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors William A. Schmalhofer, Jeffrey D. Calhoun, Rachel Burrows, Molecular Pharmacology	2008	300
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound Ana Catarina Silva, Elisabet González‐Mira, María L. García, Colloids and Surfaces B Biointerfaces NanoparticlesLipid PreparationEngineeringNanomaterialsBiocompatibility Studies	2011	288
Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Guillermo Giménez‐Gallego, Manuel A. Navia, J. P. Reuben, Proceedings of the National Academy of Sciences Crystal StructureToxinologyMolecular BiologyChannel ProteinCellular Physiology	1988	284
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation Slavomíra Doktorovová, A. Kovacevic, María L. García, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesLipid PreparationPreclinical SafetyEngineeringNanomaterials	2016	277

Page 1